OpenEMR up to 8.4.x C-CDA Gateway ccda_gateway.php report_ccd_view privileges management
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.7 | $0-$5k | 0.00+ |
Summary
A vulnerability identified as problematic has been detected in OpenEMR up to 8.4.x. Impacted is the function report_ccd_view of the file ccdaservice/ccda_gateway.php of the component C-CDA Gateway. This manipulation causes privileges management.
This vulnerability is tracked as CVE-2026-126439. The attack is possible to be carried out remotely. No exploit exists.
You should upgrade the affected component.
Details
A vulnerability has been found in OpenEMR up to 8.4.x and classified as problematic. Affected by this vulnerability is the function report_ccd_view of the file ccdaservice/ccda_gateway.php of the component C-CDA Gateway. The manipulation with an unknown input leads to a privileges management vulnerability. The CWE definition for the vulnerability is CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. As an impact it is known to affect confidentiality. The summary by CVE is:
OpenEMR before 8.5.0 contains a missing authorization vulnerability in ccdaservice/ccda_gateway.php that fails to enforce the patients/pat_rep permission, accepting any authenticated core session. Authenticated users without patient-report permission can request the report_ccd_view action to retrieve the selected patient's C-CDA clinical summary, including diagnoses, medications, laboratory results, and identifiers.
The advisory is shared at github.com. This vulnerability is known as CVE-2026-126439 since 11/10/2026. The exploitation appears to be easy. The attack can be launched remotely. Technical details are known, but no exploit is available. MITRE ATT&CK project uses the attack technique T1068 for this issue.
By approaching the search of inurl:ccdaservice/ccda_gateway.php it is possible to find vulnerable targets with Google Hacking.
Upgrading to version 8.5.0 eliminates this vulnerability.
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Name
Version
License
Website
- Product: https://github.com/openemr/openemr/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 4.8VulDB Meta Temp Score: 4.7
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 5.3
CNA Vector (VulnCheck): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Privileges managementCWE: CWE-269 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Google Hack: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Upgrade: OpenEMR 8.5.0
Timeline
11/10/2026 CVE reserved11/13/2026 Advisory disclosed
11/13/2026 VulDB entry created
11/13/2026 VulDB entry last update
Sources
Product: github.comAdvisory: github.com
Status: Confirmed
CNA: VulnCheck
CVE: CVE-2026-126439 (🔒)
GCVE (CVE): GCVE-0-2026-126439
GCVE (VulDB): GCVE-100-436837
Entry
Created: 11/13/2026 11:40Changes: 11/13/2026 11:40 (78)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.